Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.36 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.35 |
| ▸ | CDC7 | O00311 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12482200 | 0.84 | LMNA (0.52) | LMNABCHEACHETSHRKDM4E | |
| SCHEMBL6368240 | 0.84 | LMNA (0.52) | LMNABCHEACHETSHRKDM4E | |
| SCHEMBL19524651 | 0.83 | — | — | |
| SCHEMBL16125402 | 0.81 | PLA2G6 (0.41) | — | |
| SCHEMBL8859197 | 0.77 | FASN (0.45) | LMNAALDH1A1L3MBTL1POLBMEN1 | |
| SCHEMBL8888020 | 0.77 | LTA4H (0.49) | BCHEEPHX2MEN1KMT2A | |
| SCHEMBL8121733 | 0.76 | HTT (0.54) | LMNAL3MBTL1MEN1KMT2A | |
| SCHEMBL8121735 | 0.76 | HTT (0.54) | LMNAL3MBTL1MEN1KMT2A | |
| SCHEMBL8888862 | 0.76 | MGLL (0.50) | BCHEEPHX2MEN1KMT2A | |
| SCHEMBL8121731 | 0.76 | HTT (0.54) | LMNAL3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3572408-B1 | METHOD FOR PURIFYING AN AMINO ACID-N-CARBOXY ANHYDRIDE | SHINETSU CHEMICAL CO (JP) | 2021-10-27 | — | — | EP | disclosed |
| US-10975042-B2 | Method for purifying an amino acid-n-carboxy anhydride | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10975042-B2 | Method for purifying an amino acid-n-carboxy anhydride | NAAA, NPPA, NCAPH | LMNA 2223/4885NAAA 1/4885BCHE 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.